VinodhPillaiMD
Pathology • Philadelphia, PAHematopathology, Anatomic Pathology, Clinical Pathology
Physician
Are you Dr. Pillai?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 14 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
800 Spruce St
Philadelphia, PA 19107Phone+1 215-829-3000Fax+1 215-829-7564
Summary
- Dr. Vinodh Pillai, MD is a board certified pathologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, Texas, and California. He is affiliated with Pennsylvania Hospital, Hospital of the University of Pennsylvania, and Children's Hospital of Philadelphia.
Education & Training
Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2009 - 2013
Madras Medical CollegeClass of 2002
Certifications & Licensure
NJ State Medical License 2018 - 2025
CA State Medical License 2020 - 2024
OH State Medical License 2020 - 2024
PA State Medical License 2013 - 2024
TN State Medical License 2020 - 2024
CT State Medical License 2020 - 2023
IL State Medical License 2020 - 2023- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Pathology - Hematology
- Join now to see all
Publications & Presentations
PubMed
- 74 citationsRepeated loss of target surface antigen after immunotherapy in primary mediastinal large B cell lymphomaHui Yu, Elena Sotillo, Colleen T. Harrington, Gerald Wertheim, Michele Paessler
American Journal of Hematology. 2017-01-01 - 4 citationsSpontaneous remission of acute lymphoblastic leukemia: A series of nine cases and a review of literature.Timothy Kirtek, Hanan Hamdan, John S Van Arnam, Sunita Park, Alexandra E Kovach
International Journal of Laboratory Hematology. 2023-08-01 - 133 citationsCAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy.Vinodh Pillai, Kavitha Muralidharan, Wenzhao Meng, Asen Bagashev, Derek A. Oldridge
Blood Advances. 2019-11-26
Press Mentions
Translating Cancer Immunotherapy into COVID-19 MedicineAugust 25th, 2020- HTG Announces Recipients of Its 2020 HTG EdgeSeq Autoimmune Panel Research GrantsJuly 23rd, 2020
PRESS RELEASE: Alex’s Lemonade Stand Foundation Announces Pediatric Oncology Student Training (POST) Grant RecipientsAugust 10th, 2018
